Who
A. Blaine Bowman
Director
Company insider
Files Form 4 as: Director, Personalis; Director, Illumina; Director, Altera; Director, Dionex Corp /de; Director, Molecular Devices; Director, Solexa.
In numbers
- Trades disclosed
- 692
- Buys
- 11
- Sells
- 67
- Bought
- $162K
- Sold
- $47.3M
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 16 May 2005
- Last trade
- 12 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 14 May 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 16 May 2025filed 20 May 2025 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 17 May 2023filed 19 May 2023 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 17 May 2022filed 19 May 2022 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,035 at $0.00 | filing |
| 17 May 2022filed 19 May 2022 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —10,770 at $0.00 | filing |
| 14 May 2021filed 18 May 2021 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,229 at $0.00 | filing |
| 14 May 2021filed 18 May 2021 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —2,736 at $0.00 | filing |
| 15 May 2020filed 19 May 2020 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 22 May 2018filed 24 May 2018 | ILMN IlluminaLife-science tools | SEC FORM 4 Code F | $250K922 at $270.80 | filing |
| 1 May 2018filed 3 May 2018 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,800 at $0.00 | filing |
| 1 May 2018filed 3 May 2018 | ILMN Illuminaoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,200 at $0.00 | filing |
| 1 May 2018filed 3 May 2018 | ILMN IlluminaLife-science tools | SEC FORM 4 Code M | $80K1,800 at $44.51 | filing |
| 1 May 2018filed 3 May 2018 | ILMN IlluminaLife-science tools | SEC FORM 4 Code M | $85K1,200 at $71.09 | filing |
| 1 May 2018filed 3 May 2018 | ILMN IlluminaLife-science tools | SEC FORM 4 Sold | $337K1,400 at $240.90 | filing |
| 1 May 2018filed 3 May 2018 | ILMN IlluminaLife-science tools | SEC FORM 4 Sold | $339K1,400 at $241.81 | filing |
| 1 May 2018filed 3 May 2018 | ILMN IlluminaLife-science tools | SEC FORM 4 Sold | $49K200 at $242.73 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Illumina's (ILMN) Sequencing Business Is Recovering, But Is the Stock Getting Ahead of Itself?ILMN · insidermonkey.com · 13 Oct 2026Illumina (NASDAQ:ILMN) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysILMN · themarketsdaily.com · 7 Oct 2026
0 headlines in the last 90 days name A. Blaine Bowman; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.